The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

VEKLURY remdesivir 100 mg powder for injection vial (338419)

ARTG ID 338419

ARTG Name

VEKLURY remdesivir 100 mg powder for injection vial

Product name

VEKLURY remdesivir 100 mg powder for injection vial

ARTG Date

10 July 2020

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

remdesivir

Licence category

REP

Licence status

A

Summary

Product Information

Consumer Medicine Information

VEKLURY remdesivir 100 mg powder for injection vial, Gilead Sciences Pty Ltd, CON-864

13 September 2021

Section 14 consent

Consent to while noncompliant with standards.
VEKLURY remdesivir 100 mg powder for injection vial, Gilead Sciences Pty Ltd, CON-907

4 February 2022

Section 14 consent

Consent to while noncompliant with standards. The consent is effective from 4 February 2022 until 10 July 2022.